Uni Medica

Uni Medica Diagnostics

Shenzhen Uni-medica Technology Co., Ltd (Uni-medica) is a national high-tech enterprise. It has established cooperation and jointly performed a number of scientific research projects with the Hong Kong University of Science and Technology, Shenzhen University and Chinese Academy of Sciences. Uni-medica was also selected as one of the top 100 new Chinese innovative enterprises. The company takes the technical innovation of molecular detection methods as the core driving force and focuses on the R& D and industrialization of molecular diagnostic products aiming at prevention and control of infectious diseases and genetic diseases. Uni-medica provides total solution of accurate diagnosis of infectious diseases and genetic diseases based on multi-omics technologies, including multiplex PCR, NGS technology and flow cytometry. Uni-medica is qualified by ISO 13485 and CFDA quality control system. The pathogen molecular detection products are daily used in hundreds of hospitals, Centers for Disease Control and Prevention and Quarantine Laboratories throughout the country, providing strong support for prevention and control of infectious diseases.

Total Solution for SARS-CoV-2 and Variants

Uni-medica provides a high-throughput and rapid solution for screening and detecting COVID-19 during medical observation and in suspected population. It includes:

  • Automatic Nucleic Acid Extraction System (Extractor & Kits).
  • Real Time PCR Amplification System.

Fully-automatic Nucleic Acid Extractors:

Specimen: Whole Blood, bacteria, plasmid, virus, serum free and plant samples etc.

96 Extractions 10 to 13 Min depending on reganets)
32 Extractions 10 to 13 Min depending on reganets)

Real Time Fluorescence Quantitative PCR System (MA6000)